Practice Guidelines For The Administration Of Buprenorphine For Treating Opioid Use Disorder

The guidelines were released on April 28, 2021, by the federal Department of Health and Human Services. They allow eligible physicians, physician assistants, nurse practitioners, clinical nurse specialists, certified registered nurse anesthetists, and certified nurse midwives, who are state licensed and registered by the DEA to prescribe buprenorphine to treat consumers with opioid use disorder without certifying as to their capacity to provide counseling and ancillary services . . .